TECHNOLOGY LICENSING OPPORTUNITY: PlagueGuard Antibodies
S-133813 · ENERGY, DEPARTMENT OF
A BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING solicitation, performed in Los Alamos, NM, with responses due 2025-10-10. AwardCast estimates what this specific solicitation will close for, before you bid.
What's being bought
Los Alamos National Laboratory scientists have developed high-affinity human antibodies that can quickly detect and potentially treat deadly, antibiotic-resistant plague infections, helping protect against both natural outbreaks and bioterror threats. The Challenge: Plague, caused by the bacterium Y
Comparable recent awards in BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING
| Winner | Award value | Offers | Date |
|---|---|---|---|
| JACKSON LABORATORY | $3.0M | 1 | 2026-07-01 |
| BANNER HEALTH | $30K | 1 | 2026-06-26 |
| BOEHRINGER INGELHEIM ANIMAL HEALTH FRANCE | $3.7M | n/a | 2026-06-26 |
| LIFE TECHNOLOGIES CORPORATION | $51K | 1 | 2026-06-26 |
| REPROCELL U.S.A., INC. | $32K | 1 | 2026-06-22 |
Questions
What is solicitation S-133813?
TECHNOLOGY LICENSING OPPORTUNITY: PlagueGuard Antibodies, issued by ENERGY, DEPARTMENT OF, under NAICS 325414 (BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING), performed in Los Alamos, NM. Responses are due 2025-10-10.
What do similar contracts close for?
Comparable closed awards in this category ran from $30K to $3.7M, across 5 awards shown above. Those are historical results, not a forecast for this solicitation.
Is S-133813 set aside?
NONE. Check the notice on SAM.gov for the eligibility language that governs.
Explore the market
Forecast Report — what a specific solicitation will close for: the predicted price range, the competition to expect, and comparable awards already closed. Before you price your bid.
Every forecast is scored against the real award once it becomes public. See the track record.
Closed awards from public federal data, not the forecast. One email, no account.
Or get the forecast for this solicitation — $49, one report.